Intuitive Surgical, Inc. (NASDAQ:ISRG) last session’s volume of 0.98 million shares was higher than its average volume of 0.88 million shares. The stock, after opening at $372.64, hit $371.49 through the close by scoring -0.54%.Intuitive Surgical, Inc. (ISRG) Analyst Opinion
Intuitive Surgical, Inc. has a consensus outperform rating from 18 Wall Street analysts, and the number of shares currently sold short amount to at least 1.51% of shares outstanding. The stock spiked 9.55% last month and is up 75.74 this year. Wall Street is only getting more bullish on the stock, with 11 of analysts who cover ISRG having a buy-equivalent rating. Analysts have placed a $345.89 price target on Intuitive Surgical, Inc., suggesting a -6.89% decline from recent close. It’s currently trading about -1.81% below its 52-week high.
Intuitive Surgical, Inc. (ISRG) surprised the stock market in its last reported earnings when it earned $2.77 a piece versus the consensus-estimated $1.99. Its revenue totaled $753.15 million down -0.4% from the previous quarter.Intuitive Surgical, Inc. (NASDAQ:ISRG) Intraday View
This stock (ISRG) is ahead of its 52-week low with 82.49%. Its last month’s stock price volatility remained 2.22% which for the week stands at 1.67%. The share price has moved forward from its 20 days moving average, trading at a distance of 4.25% and stays 7.69% away from its 50 days moving average. Over the last five days, shares have managed 4.65% gains and now is up 27.31% since hitting its 200-day moving average of $316.02. Intuitive Surgical, Inc. (ISRG) has made its way to a 12-month gain of 62.7%.
Turning to Inovio Pharmaceuticals, Inc. (NASDAQ:INO), its shares were trading at $5.79 a retreat of $-0.13, on the trading floor. The stock, after opening at $5.98, touched a high of $6.04 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.7. Inovio Pharmaceuticals, Inc. has 2 buy ratings, 0 holds and 0 sells even after the stock tumbled -41.28% from its high of $ 9.86 to a $524.05 million market value through last close.
The company’s consensus rating on Reuter’s scale improved from 1.67 to 1.71 during a month. Analysts set a 12-month price target of $11.71 a share. The target implies a 102.25% spike from where the shares are currently trading. Also, the current price highlights a discount of 141.8% to analysts’ high consensus price target.Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Intraday Trading
The counter witnessed a trading volume of 1.67 million shares versus an average volume of 1.29 million shares during last trading session. Its last month’s stock price volatility remained 3.56% which for the week approaches 3.33%. The lowest price the stock reached in the last trading day was $5.7825 and compares with the $5.28 52-week low. The stock recovered 9.66% since its low point and has performed -16.57% year-to-date.